Other
Periodontal Pocket
5
Pipeline Programs↗
0
Active Trials↗
6
Companies Involved↗
Periodontal Pocket is an early-stage landscape with 5 programs across 6 companies. The most active players are Merck & Co., Novartis, Dexcel Pharma Technologies Ltd.. 2 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 11
Phase 21
Phase 3
No programs
Analysis
Trial Status
7
clinical trials
Completed6 · 86%
Unknown status1 · 14%
Clinical Trials
Trial Activity
7 trials
Effect of Hyaluronic Acid in the Treatment of Periodontal Pockets
Completed·—·N/A·NCT02170857·30 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)